Healthcare system Novant Health Inc on Wednesday introduced America's first emergency drone logistics operation in response to COVID-19 pandemic in partnership with Zipline, which will provide drone flight services during the crisis in North Carolina.
The US Federal Aviation Administration (FAA) granted Novant Health a Part 107 waiver to begin operation, which is being launched as part of the North Carolina Department of Transportation's (NCDOT's) Unmanned Aircraft System Integration Pilot Program (IPP). The operation will provide ongoing drone logistics flights in Class-D controlled airspace under a part 107 waiver issued to a healthcare system.
This operation provides contactless distribution of personal protective equipment and critical medical supplies to Novant Health frontline medical teams in the Charlotte, North Carolina, metro area. The operation helps position Novant Health to adapt quickly to the evolving pandemic and could lead to innovative uses including testing, drug trials and vaccine distribution in the future.
Subject to approval under FAA Part 135 rules, the partnership plans to expand beyond emergency operations in the Charlotte area to regular commercial operations to serve health facilities and, ultimately, patients' homes across the state.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses